You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neuroendocrine neoplasms

Showing 1 - 25 of 1,897
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GEP-NET, Neuroendocrine Tumors, Neuroendocrine Carcinoma Trial in Copenhagen (18F-FDG, 64Cu-Dotatate)

Enrolling by invitation
  • GEP-NET
  • +3 more
  • Copenhagen, Denmark
    Rigshospitalet
Jan 24, 2023

Neuroendocrine Neoplasms Including Adrenocortical Carcinoma

Recruiting
  • Neuroendocrine Tumors
  • Carcinoma, Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Neuroendocrine Tumors Trial in Innsbruck, Kraków, Ljubljana ([99mTc]Tc-TECANT1)

    Recruiting
    • Neuroendocrine Tumors
    • Innsbruck, Austria
    • +2 more
    May 12, 2023

    Genetic Predisposition Testing Program for Pancreatic

    Not yet recruiting
    • Pancreatic Neuroendocrine Neoplasm
    • Hereditary Cancer Panel
    • Los Angeles, California
    • +2 more
    Feb 17, 2023

    Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, Ezabenlimab)

    Not yet recruiting
    • Small Cell Lung Carcinoma (SCLC)
    • Neuroendocrine Neoplasms
    • (no location specified)
    May 25, 2023

    Neuroendocrine Neoplasms Methylation Based Classifier - The

    Enrolling by invitation
    • Neuroendocrine Tumors
    • Methylation analysis
    • Basel, Basel Stadt, Switzerland
      University Hospital Basel, Department of Endocrinology
    May 17, 2022

    Neuroendocrine Tumors, Frailty, Chemo Effect Trial in Milan (Temozolomide capsule)

    Recruiting
    • Neuroendocrine Tumors
    • +2 more
    • Temozolomide capsule
    • Milan, Italy
      European Institute of Oncology, IEO, IRCCS
    Sep 21, 2022

    Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, [89Zr]Zr-BI 764532)

    Not yet recruiting
    • Small Cell Lung Carcinoma (SCLC)
    • Neuroendocrine Neoplasms
    • BI 764532
    • [89Zr]Zr-BI 764532
    • (no location specified)
    Jul 31, 2023

    Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

    Recruiting
    • Gastroenteropancreatico Tumors
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    Pancreatic Neuroendocrine Tumor Trial in Shanghai (Nimotuzumab)

    Not yet recruiting
    • Pancreatic Neuroendocrine Neoplasm
    • Shanghai, Shanghai, China
      Department of Pancreatic Surgery, Fudan University Shanghai Canc
    Apr 4, 2022

    Neuroendocrine Tumors Trial (BI 764532, Carboplatin, Etoposide)

    Not yet recruiting
    • Neuroendocrine Neoplasms
    • BI 764532
    • +3 more
    • (no location specified)
    Nov 10, 2023

    Neuroendocrine Tumors, Neuroendocrine Carcinoma, Pancreas Tumor Trial in Roma, Rome (EUS guided radiofrequency ablation)

    Recruiting
    • Neuroendocrine Tumors
    • +3 more
    • EUS guided radiofrequency ablation
    • Roma, RM, Italy
    • +1 more
    Feb 10, 2022

    Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

    Not yet recruiting
    • Pancreatic Adenocarcinoma
    • +6 more
    • (no location specified)
    Aug 4, 2023

    Pancreatic Neuroendocrine Tumors, WHO Grade I-II Trial in Oslo (Radio frequency ablation)

    Recruiting
    • Pancreatic Neuroendocrine Tumors, WHO Grade I-II
    • Radio frequency ablation
    • Oslo, Norway
      Oslo University Hospital
    Feb 7, 2022

    Small Cell Lung Carcinoma, Neuroendocrine Tumors Trial (BI 764532)

    Not yet recruiting
    • Small Cell Lung Carcinoma
    • Neuroendocrine Neoplasms
    • BI 764532
    • (no location specified)
    May 22, 2023

    High Grade Neuroendocrine Tumors Trial in Saint Louis (Cabozantinib, Blood for plasma biomarkers, Tissue biopsy)

    Recruiting
    • High Grade Neuroendocrine Neoplasms
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 11, 2021

    Gastroenteropancreatic Neuroendocrine Tumours

    Recruiting
    • Gastroenteropancreatic Neuroendocrine Tumor
    • 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included
    • Milano, Italy
      Irccs San Raffaele
    Nov 24, 2023

    Pheochromocytoma, Paraganglioma, Neuroendocrine Tumors Trial run by the NCI (Lu-177-DOTATATE, Ga-68-DOTATATE, F-18-FDG)

    Recruiting
    • Pheochromocytoma
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    Quality of Life Trial in Belgium (EORTC QLQ-C30, EORTC QLQ-GI.NET21, Satisfaction survey)

    Recruiting
    • Quality of Life
    • EORTC QLQ-C30
    • +2 more
    • Brasschaat, Antwerp, Belgium
    • +6 more
    Mar 8, 2022

    Clinical Relevance of Salvage Treatment for Colorectal

    Completed
    • Rectal Neoplasms
    • Neuroendocrine Tumors
    • salvage treatment
    • (no location specified)
    Nov 16, 2023

    Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1 Trial in Iowa City ([212Pb] VMT-a-NET,

    Recruiting
    • Neuroendocrine Tumors
    • +4 more
    • [212Pb] VMT-α-NET
    • [203Pb] VMT-α-NET SPECT/CT
    • Iowa City, Iowa
      Holden Comprehensive Cancer Center at the University of Iowa
    Nov 30, 2023

    Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

    Not yet recruiting
    • Digestive System Neuroendocrine Tumor G1
    • +5 more
    • Tumor Debulking
    • +5 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Aug 23, 2023

    Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +4 more
    • Newport Beach, California
    • +2 more
    Aug 16, 2023

    Advanced Solid Tumors With Neuroendocrine Differentiation Trial (surufatinib?serplulimab)

    Not yet recruiting
    • Advanced Solid Tumors With Neuroendocrine Differentiation
    • (no location specified)
    Nov 27, 2023

    Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

    Not yet recruiting
    • Neuroendocrine Tumors
    • +8 more
    • Iowa City, Iowa
    • +1 more
    Nov 23, 2022